Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

被引：0
|
作者：
Emilie Thivat
Mélanie Casile
Juliette Moreau
Ioana Molnar
Sandrine Dufort
Khalide Seddik
Géraldine Le Duc
Olivier De Beaumont
Markus Loeffler
Xavier Durando
Julian Biau
机构：
[1] Centre Jean Perrin,Department of Clinical Research, Délégation Recherche Clinique Et Innovation
[2] INSERM U1240 IMoST,Department of Radiation Oncology
[3] Université Clermont Auvergne,Oncology Department
[4] UMR 501,undefined
[5] Centre d’Investigation Clinique,undefined
[6] Centre Jean Perrin,undefined
[7] NH TherAguix SA,undefined
[8] Centre Jean Perrin,undefined
来源：
BMC Cancer | / 23卷
关键词：
Glioblastoma; Nanoparticles; AGuIX; Nanomedicine; Radiotherapy; Radiosensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress
    Khasraw, Mustafa
    McDonald, Kerrie L.
    Yip, Sonia
    Verhaak, Roel
    Heimberger, Amy
    Hall, Merryn
    Fisher, Lauren
    Barnes, Elizabeth
    Rosenthal, Mark
    Gedye, Craig
    Hovey, Elizabeth
    Ellingson, Benjamin M.
    Simes, John
    Tongela, Annette
    Wheeler, Helen
    Koh, Eng-Siew
    Gan, Hui
    Back, Michael
    Lwin, Zarnie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 196 - 197
  • [32] NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS
    Khasraw, Mustafa
    McDonald, Kerrie
    Yip, Sonia
    Verhaak, Roel
    Heimberger, Amy
    Hall, Merryn
    Fisher, Lauren
    Barnes, Elizabeth
    Rosenthal, Mark
    Gedye, Craig
    Hovey, Elizabeth
    Ellingson, Benjamin
    Simes, John
    Tognela, Annette
    Koh, Eng-Siew
    Gan, Hui
    Back, Michael
    Lwin, Zarnie
    NEURO-ONCOLOGY, 2018, 20 : 235 - 235
  • [33] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [35] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [36] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [37] Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).
    Sarkaria, Jann Nagina
    Ballman, Karla V.
    Kizilbash, Sani Haider
    Sulman, Erik P.
    Giannini, Caterina
    Mashru, Sandeep H.
    Piccioni, David Eric
    Friday, Bret Edward Buckley
    Dixon, Jesse G.
    Kabat, Brian
    Laack, Nadia N.
    Hu, Leland
    Kumthekar, Priya
    Ellingson, Benjamin M.
    Anderson, S. Keith
    Galanis, Evanthia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [39] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 79 - 79
  • [40] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
12345